Ko Y - Search Results

1

Practitioners' views on computerized drug-drug interaction alerts in the VA system.

Ko Y, Abarca J, Malone DC, Dare DC, Geraets D, Houranieh A, Jones WN, Nichol WP, Schepers GP, Wilhardt M. Ko Y, et al. J Am Med Inform Assoc. 2007 Jan-Feb;14(1):56-64. doi: 10.1197/jamia.M2224. Epub 2006 Oct 26. J Am Med Inform Assoc. 2007. PMID: 17068346 Free PMC article.

2

Reasons provided by prescribers when overriding drug-drug interaction alerts.

Grizzle AJ, Mahmood MH, Ko Y, Murphy JE, Armstrong EP, Skrepnek GH, Jones WN, Schepers GP, Nichol WP, Houranieh A, Dare DC, Hoey CT, Malone DC. Grizzle AJ, et al. Among authors: ko y. Am J Manag Care. 2007 Oct;13(10):573-8. Am J Manag Care. 2007. PMID: 17927462 Free article.

3

Potential drug-drug interactions within Veterans Affairs medical centers.

Mahmood M, Malone DC, Skrepnek GH, Abarca J, Armstrong EP, Murphy JE, Grizzle AJ, Ko Y, Woosley RL. Mahmood M, et al. Among authors: ko y. Am J Health Syst Pharm. 2007 Jul 15;64(14):1500-5. doi: 10.2146/ajhp060548. Am J Health Syst Pharm. 2007. PMID: 17617500

4

Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.

Ko Y, Malone DC, Skrepnek GH, Armstrong EP, Murphy JE, Abarca J, Rehfeld RA, Reel SJ, Woosley RL. Ko Y, et al. Drug Saf. 2008;31(6):525-36. doi: 10.2165/00002018-200831060-00007. Drug Saf. 2008. PMID: 18484786

5

Potential determinants of prescribers' drug-drug interaction knowledge.

Ko Y, Malone DC, D'Agostino JV, Skrepnek GH, Armstrong EP, Brown M, Woosley RL. Ko Y, et al. Res Social Adm Pharm. 2008 Dec;4(4):355-66. doi: 10.1016/j.sapharm.2007.10.004. Epub 2008 Aug 8. Res Social Adm Pharm. 2008. PMID: 19064242

6

Pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladder.

Ko Y, Malone DC, Armstrong EP. Ko Y, et al. Pharmacotherapy. 2006 Dec;26(12):1694-702. doi: 10.1592/phco.26.12.1694. Pharmacotherapy. 2006. PMID: 17125433

7

Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: Short-term results from a randomized controlled trial.

Siaw MYL, Malone DC, Ko Y, Lee JY. Siaw MYL, et al. Among authors: ko y. J Clin Pharm Ther. 2018 Dec;43(6):775-783. doi: 10.1111/jcpt.12700. Epub 2018 Apr 25. J Clin Pharm Ther. 2018. PMID: 29696669 Clinical Trial.

8

Cost-utility analysis of second-line anti-diabetic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin.

Chien CL, Chen YC, Malone DC, Peng YL, Ko Y. Chien CL, et al. Among authors: ko y. Curr Med Res Opin. 2020 Oct;36(10):1619-1626. doi: 10.1080/03007995.2020.1815686. Epub 2020 Sep 8. Curr Med Res Opin. 2020. PMID: 32851879

9

Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial.

Siaw MYL, Ko Y, Malone DC, Tsou KYK, Lew YJ, Foo D, Tan E, Chan SC, Chia A, Sinaram SS, Goh KC, Lee JY. Siaw MYL, et al. Among authors: ko y. J Clin Pharm Ther. 2017 Aug;42(4):475-482. doi: 10.1111/jcpt.12536. Epub 2017 Apr 27. J Clin Pharm Ther. 2017. PMID: 28449205 Clinical Trial.

10

Diagramming patients' views of root causes of adverse drug events in ambulatory care: an online tool for planning education and research.

Brown M, Frost R, Ko Y, Woosley R. Brown M, et al. Among authors: ko y. Patient Educ Couns. 2006 Sep;62(3):302-15. doi: 10.1016/j.pec.2006.02.007. Epub 2006 Jul 31. Patient Educ Couns. 2006. PMID: 16879943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,804 results

Search Page